Cargando…

(Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort

BACKGROUND: To develop and assess a prediction model for polymyalgia rheumatica (PMR) relapse within the first year of glucocorticoid (GC) treatment. METHODS: A retrospective PMR cohort (clinical diagnosis) from a rheumatology department was used. All visits > 30 days after starting GC treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolhuis, Thomas E., Marsman, Diane, van den Hoogen, Frank H. J., Broeder, Alfons A. den, Broeder, Nathan den, van der Maas, Aatke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344672/ https://www.ncbi.nlm.nih.gov/pubmed/35915465 http://dx.doi.org/10.1186/s41927-022-00274-y

Ejemplares similares

PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial
por: Marsman, Diane E., et al.
Publicado: (2022)

Relapse of polymyalgia rheumatica after a fall
por: Manzo, Ciro, et al.
Publicado: (2017)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?
por: Bouman, Chantal A M, et al.
Publicado: (2017)

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
por: den Broeder, Alfons A, et al.
Publicado: (2013)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
por: Michielsens, Celia A. J., et al.
Publicado: (2020)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA—a retrospective, exploratory cohort study
por: Bouman, Chantal A M, et al.
Publicado: (2018)

An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study
por: Michielsens, Celia A J, et al.
Publicado: (2021)

Age-Related Health Hazards in Old Patients with First-Time Referral to a Rheumatologist: A Descriptive Study
por: van Lankveld, W., et al.
Publicado: (2011)

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
por: van Herwaarden, Noortje, et al.
Publicado: (2015)

(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges
por: den Broeder, Alfons A, et al.
Publicado: (2021)

Induction of Remission is Difficult due to Frequent Relapse during Tapering Steroids in Korean Patients with Polymyalgia Rheumatica
por: Kim, Hyoun-Ah, et al.
Publicado: (2012)

Polymyalgia rheumatica: an autoinflammatory disorder?
por: Floris, Alberto, et al.
Publicado: (2018)

Polymyalgia rheumatica: An update (Review)
por: Florescu, Mirela Marinela, et al.
Publicado: (2023)

Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care
por: Fors, Charlotta, et al.
Publicado: (2019)

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
por: den Broeder, Alfons A., et al.
Publicado: (2017)

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
por: Tweehuysen, Lieke, et al.
Publicado: (2018)

Reliability Exercise for the Polymyalgia Rheumatica Classification Criteria Study: The Oranjewoud Ultrasound Substudy
por: Scheel, Alexander K., et al.
Publicado: (2009)

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
por: Mulder, Michelle L. M., et al.
Publicado: (2020)

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2022)

Peripheral arterial disease in polymyalgia rheumatica
por: Borg, Frances A, et al.
Publicado: (2009)

Polymyalgia rheumatica in a married couple
por: Rüst, Christoph Alexander, et al.
Publicado: (2012)

A case report of polymyalgia rheumatica
por: Kniazkova, Iryna, et al.
Publicado: (2018)

Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021)

Tozinameran: Polymyalgia rheumatica: case report
Publicado: (2022)

Elasomeran: Polymyalgia rheumatica: case report
Publicado: (2022)

Tozinameran: Polymyalgia-rheumatica: case report
Publicado: (2022)

The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study
por: Prior, J.A., et al.
Publicado: (2019)

Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2021)

The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study
por: Tshimologo, Maatla, et al.
Publicado: (2018)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)
por: van der Togt, Céleste J.T., et al.
Publicado: (2022)

Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial
por: Peeters, Iris Rose, et al.
Publicado: (2023)

Anterior Uveitis as an Initial Manifestation of Polymyalgia Rheumatica
por: Tsuda, Hiromasa, et al.
Publicado: (2011)

Metastatic Prostate Cancer Mimicking Polymyalgia Rheumatica
por: Randazzo, Charles T., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m4ap3tjju7qdlb9e6ecu2pkeen